Individualized Exercise Combined With Manual Therapy in Severe Hemophilia Patients With Polyarthropathy
Effects of Individualized Exercise Intervention Combined With Manual Therapy on Musculoskeletal System, Cardiopulmonary Endurance and Quality of Life in Severe Hemophilia Patients With Polyarthropathy
2 other identifiers
interventional
10
1 country
1
Brief Summary
The aim of this study is to investigate the effect of individualized physical therapy, combined manual therapy and exercise intervention, for pain perception, range of motion (ROM), muscle strength, joint health, cardiopulmonary endurance and quality of life (QoL) in patients with severe hemophilia A and multiple hemophilic arthropathy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 5, 2024
CompletedFirst Submitted
Initial submission to the registry
July 29, 2024
CompletedFirst Posted
Study publicly available on registry
August 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMarch 2, 2026
August 1, 2025
12 months
July 29, 2024
February 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Hemophilia Joint Health Score (HJHS)
To measure joint health, in the domain of body structure and function (i.e. impairment), of the joints most commonly affected by bleeding in hemophilia: the knees, ankles, and elbows. It provides a total score (higher score is worse; max=124), joint specific scores, and a global gait score.
before intervention (baseline), after intervention 6th week and 12th week
Visual Analogue Scale (VAS)
To assess the target joint pain in hemophilia. The minimum value is 0, and the maximum value is 10 (higher score is worse).
before intervention (baseline), after intervention 6th week and 12th week
6 minute walk test
To evaluate cardiopulmonary endurance. The predictive equation for males: 6MWD(m) = 867 - (5.71 age, yrs) + (1.03 height, cm). The predictive equation for females: 6MWD(m) = 525 - (2.86 age, yrs) + (2.71 height, cm) - (6.22BMI).
before intervention (baseline), after intervention 6th week and 12th week
Hemophilia Activity List (HAL)
To measure the impact of hemophilia on self-perceived functional abilities in adults.Normalized scores for the domains, components, and the full questionnaire can also be obtained. Missing values are controlled for and the possible scores range from 0 to 100, where 0 represents the worst possible functional status and 100 the best possible functional status.
before intervention (baseline), after intervention 6th week and 12th week
EQ-5D-5L
To measure the quality of life. Each dimension now has five response levels: no problems (1), slight problems (2), moderate problems (3), severe problems (4), unable to/extreme problems (5). The minimum value is 55555 and the maximum value is 11111 (higher score is worse). EQ VAS:the minimum score is 0, and the maximum score is 100 (higher score is better).
before intervention (baseline), after intervention 6th week and 12th week
Secondary Outcomes (1)
Daily notes
once a week (each intervention) for 3 months
Study Arms (1)
Physiotherapy group
OTHERIndividualized physiotherapy intervention based on manual therapy and exercise 1 session per week for 3 months
Interventions
1. Manual therapy included fascia release, progressive passive stretch, mobilization, etc.(depend on subject's current condition) 2. Exercise included muscle strengthening, trunk (spine) stabilization exercise. (depend on subject's current condition)
Eligibility Criteria
You may qualify if:
- over 20 years old and diagnosed with severe hemophilia
- those who receive prophylaxis regularly
- there are more than 2 target joints (hemophilic arthropathy)
You may not qualify if:
- unwilling to sign the informed consent
- any neurological disease or specific musculoskeletal condition (such as fracture) one year ago
- more than 3 (excluding 3) joint replacement surgeries (different joints)
- unable to walk due to hemophilia joint disease or any other diseases
- major bleeding events that pose risks or hinder research
- unable to follow instructions due to cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Far Eastern Memorial hospital
New Taipei City, 220, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wan Jung Kao, bachelor
staff
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2024
First Posted
August 2, 2024
Study Start
July 5, 2024
Primary Completion
June 28, 2025
Study Completion
December 31, 2025
Last Updated
March 2, 2026
Record last verified: 2025-08